Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Dow
US Department of Justice
Cipla
Citi
AstraZeneca
Colorcon
Farmers Insurance
Fish and Richardson
Teva

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020301

« Back to Dashboard

NDA 020301 describes ORTHO-CEPT, which is a drug marketed by Janssen Pharms and is included in one NDA. Additional details are available on the ORTHO-CEPT profile page.

The generic ingredient in ORTHO-CEPT is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
Summary for 020301
Tradename:ORTHO-CEPT
Applicant:Janssen Pharms
Ingredient:desogestrel; ethinyl estradiol
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORAL-21Strength0.15MG;0.03MG
Approval Date:Dec 14, 1992TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORAL-28Strength0.15MG;0.03MG
Approval Date:Dec 14, 1992TE:RLD:No

Expired US Patents for NDA 020301

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms ORTHO-CEPT desogestrel; ethinyl estradiol TABLET;ORAL-21 020301-001 Dec 14, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharms ORTHO-CEPT desogestrel; ethinyl estradiol TABLET;ORAL-28 020301-002 Dec 14, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
US Department of Justice
Citi
Johnson and Johnson
Fuji
Daiichi Sankyo
McKesson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot